Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

Clinical trial NCT04653480 · UNKNOWN

Trial details

NCT number: NCT04653480
Sponsor: Zhejiang University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2021-02-01
Primary completion: 2025-06-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.